Momparler R L, Doré B T, Momparler L F
Departement de Pharmacologie, Université de Montréal, Québec, Canada.
Cancer Lett. 1990 Oct 8;54(1-2):21-8. doi: 10.1016/0304-3835(90)90086-d.
The antineoplastic effects of 5-aza-2'-deoxycytidine (5-AZA-CdR) and retinoic acid on human HL-60 myeloid leukemic cells were investigated. 5-AZA-CdR or retinoic acid reduced the clonogenicity and induced the differentiation of HL-60 leukemic cells. The effects produced by 5-AZA-CdR and retinoic acid in combination on clonogenicity and differentiation of HL-60 leukemic cells were additive. These agents in combination also produced an additive decrease in the mRNA expression of the c-myc. These data indicate that 5-AZA-CdR and retinoic acid in combination produce an additive antineoplastic effect against HL-60 human myeloid leukemic cells.
研究了5-氮杂-2'-脱氧胞苷(5-AZA-CdR)和视黄酸对人HL-60髓系白血病细胞的抗肿瘤作用。5-AZA-CdR或视黄酸降低了HL-60白血病细胞的克隆形成能力并诱导其分化。5-AZA-CdR和视黄酸联合使用对HL-60白血病细胞克隆形成能力和分化的影响是相加的。这些药物联合使用还使c-myc的mRNA表达呈相加性降低。这些数据表明,5-AZA-CdR和视黄酸联合使用对人HL-60髓系白血病细胞产生相加的抗肿瘤作用。